General dosing guidelines; consult specific product labeling; however, the dose of psyllium should be gradually increased to effect along with dietary intake changes.
Constipation: Oral: Psyllium: 2.5 to 30 g per day in divided doses
Reduce risk of coronary heart disease: Oral: Soluble fiber ≥7 g (psyllium seed husk ≥10.2 g) per day (DHHS 1998)
Diabetes mellitus, type 2 (adjunctive therapy) (off-label use): Oral: 6.8 to 13.6 g/day in 2 divided doses (Abutair 2016; Feinglos 2013)
Irritable bowel syndrome, unspecified (off-label use):
Note: General dosing guidelines provided; also, consult specific product labeling. The dose of psyllium should be gradually increased to effect along with dietary modification.
Oral: Initial: 3 to 4 g soluble fiber per day in 1 or 2 divided doses; titrate every 1 to 2 weeks to achieve a recommended daily fiber intake of 25 to 35 g (ACG [Lacy 2021]; Bijkerk 2009; Vasant 2021).
There are no dosage adjustments provided in the manufacturer's labeling.
There are no dosage adjustments provided in the manufacturer's labeling.
Refer to adult dosing.
(For additional information see "Psyllium: Pediatric drug information")
Adequate intake for total fiber: Note: The definition of "fiber" varies; however, the soluble fiber in psyllium is only one type of fiber which makes up the daily recommended intake of total fiber; contribution from other food sources should also be considered when assessing intake. Reported requirements variable:
USDA recommendations:
Children 2 to 3 years: 14 g/day.
Children 4 to 8 years: Female: 17 g/day; Male: 20 g/day.
Children and Adolescents 9 to 13 years: Female: 22 g/day; Male: 25 g/day.
Adolescents: 14 to 18 years: Female: 25 g/day; Male: 31 g/day.
Bowel movement regularity: Note: Ensure adequate water intake. Use of fiber (either dietary or supplemental) has not shown efficacy in pediatric patients for treatment of constipation and NASPGHAN guidelines do not recommend the use of fiber supplements (NASPGHAN [Tabbers 2014]).
General dosing guidelines (Federal Register 1985); consult specific product labeling for details:
Children 6 to <12 years: Oral: 1.25 to 15 g/day in 1 to 3 divided doses.
Children ≥12 years and Adolescents: Oral: 2.5 to 30 g/day in 1 to 3 divided doses.
Hypercholesterolemia; adjunct treatment with dietary management: Limited data available (AACE [Jellinger 2017]; NHLBI 2011):
Children 2 to <12 years: Oral: 6 g/day in 1 to 3 divided doses.
Children ≥12 years and Adolescents: Oral: 12 g/day in 1 to 3 divided doses.
There are no dosage adjustments provided in the manufacturer's labeling.
There are no dosage adjustments provided in the manufacturer's labeling.
The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.
Gastrointestinal: Abdominal cramps, constipation, diarrhea, esophageal obstruction, intestinal obstruction
Hypersensitivity: Anaphylaxis (upon inhalation in susceptible individuals)
Ophthalmic: Allergic conjunctivitis (rhinoconjunctivitis)
Respiratory: Bronchospasm
Hypersensitivity to psyllium or any component of the formulation; fecal impaction; GI obstruction
Concerns related to adverse effects:
• Hypersensitivity reactions: Hypersensitivity reactions have been reported with ingestion or inhalation of psyllium in susceptible individuals.
Disease-related concerns:
• Coronary heart disease (CHD): To reduce the risk of CHD, the soluble fiber from psyllium should be used in conjunction with a diet low in saturated fat and cholesterol.
• Gastrointestinal disease: Use with caution in patients with esophageal strictures, ulcers, stenosis, or intestinal adhesions or difficulty swallowing
Special populations:
• Older adult: Use with caution in the elderly; may have insufficient fluid intake which may predispose them to fecal impaction and bowel obstruction.
Dosage form specific issues:
• Calcium: Some products may contain calcium.
• Phenylalanine: Some products may contain phenylalanine.
• Potassium: Some products may contain potassium.
• Sodium: Some products may contain sodium.
• Soy lecithin: Some products may contain soy lecithin.
Other warnings/precautions:
• Administration: Products must be taken with at least 8 ounces of fluid in order to prevent choking.
• Self-medication (OTC use): When used for self-medication (OTC), do not use in the presence of abdominal pain, nausea, or vomiting. Notify healthcare provider in case of sudden changes of bowel habits which last >2 weeks or in case of rectal bleeding. Not for self-treatment of constipation lasting >1 week.
Psyllium hydrophilic mucilloid 3.4 g is equivalent to 2 g Soluble fiber
Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product
Capsule, Oral [preservative free]:
Reguloid: 400 mg [DSC] [fish derivative free, gluten free, milk free, no artificial flavor(s), nut free, soy free, starch free, sugar free, yeast free]
Packet, Oral:
Konsyl Daily Fiber: 28.3% (1 ea [DSC], 30 ea [DSC]) [gluten free; contains fd&c yellow #6 (sunset yellow), quinoline yellow (d&c yellow #10); orange flavor]
Konsyl Daily Fiber: 100% (1 ea [DSC], 30 ea [DSC], 100 ea) [gluten free, kosher certified, sugar free; bland flavor]
Konsyl Daily Fiber: 60.3% (30 ea [DSC]) [gluten free, sugar free; contains fd&c yellow #6 (sunset yellow)]
Konsyl Original Daily Fiber: 100% (30 ea [DSC]) [gluten free, sugar free]
Metamucil 4 in 1 Fiber: 25% (30 ea) [gluten free; contains fd&c yellow #6 (sunset yellow); orange flavor]
Metamucil 4 in 1 Fiber: 51.7% (30 ea) [gluten free, sugar free; contains aspartame, fd&c yellow #6 (sunset yellow)]
Powder, Oral:
Geri-Mucil: 25% (368 g) [contains fd&c yellow #6 (sunset yellow), fd&c yellow #6(sunset yellow)alumin lake]
Geri-Mucil: 68% (368 g [DSC])
Geri-Mucil: 68% (283 g [DSC]) [sugar free]
Konsyl: 30.9% (397 g [DSC]) [gluten free, kosher certified; contains fd&c yellow #6 (sunset yellow)]
Konsyl: 60.3% (450 g [DSC]) [gluten free, kosher certified, sugar free; contains aspartame, fd&c yellow #6 (sunset yellow)]
Konsyl: 71.67% (300 g [DSC]) [gluten free, kosher certified, sugar free]
Konsyl: 60.3% (283 g [DSC]) [sugar free; contains aspartame, fd&c yellow #6 (sunset yellow)]
Konsyl Daily Fiber: 28.3% (538 g) [gluten free; contains fd&c yellow #6 (sunset yellow), quinoline yellow (d&c yellow #10); orange flavor]
Konsyl Daily Fiber: 100% (300 g [DSC], 450 g [DSC]) [gluten free, kosher certified; bland flavor]
Konsyl Daily Fiber: 60.3% (450 g) [gluten free, sugar free; contains fd&c yellow #6 (sunset yellow)]
Konsyl-D: 52.3% (397 g [DSC]) [flavor free; sweet flavor]
Metamucil: 28.3% (575 g [DSC])
Metamucil MultiHealth Fiber: 63% (660 g) [gluten free, sugar free]
Natural Fiber Therapy: 48.57% (538 g [DSC])
Natural Psyllium Seed: 100% (480 g) [animal products free, gelatin free, gluten free, kosher certified, lactose free, no artificial color(s), no artificial flavor(s), starch free, sugar free, yeast free]
Natural Vegetable Fiber: 48.57% (368 g [DSC])
OneLAX Daily Fiber: 83% (300 g) [sugar free]
OneLAX Fiber Therapy: 25% (368 g) [contains fd&c yellow #6 (sunset yellow), sodium benzoate]
OneLAX Fiber Therapy: 25% (368 g) [gluten free, sugar free; contains fd&c yellow #6 (sunset yellow), sodium benzoate; orange flavor]
Reguloid: 48.57% (369 g [DSC], 540 g [DSC])
Reguloid: 28.3% (540 g [DSC]) [contains fd&c yellow #6 (sunset yellow), fd&c yellow #6(sunset yellow)alumin lake]
Reguloid: 58.6% (284 g [DSC]) [sugar free]
Reguloid: 58.6% (284 g [DSC]) [sugar free; contains aspartame, fd&c yellow #6 (sunset yellow), fd&c yellow #6(sunset yellow)alumin lake]
Generic: 28.3% (368 g)
Powder, Oral [preservative free]:
Evac: (480 g) [dye free]
May be product dependent
Pack (Metamucil 4 in 1 Fiber Oral)
51.7% (per each): $0.55
Powder (OneLAX Daily Fiber Oral)
83% (per gram): $0.03
Powder (OneLAX Fiber Therapy Oral)
25% (per gram): $0.03
Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.
Inhalation of psyllium dust may cause sensitivity to psyllium (eg, runny nose, watery eyes, wheezing). Drink at least 8 ounces of liquid with each dose. Powder must be mixed in a glass of water or juice. Capsules should be swallowed one at a time. When more than one dose is required, they should be divided throughout the day. Separate dose by at least 2 hours from other drug therapies.
Diabetes mellitus, type 2 (adjunctive therapy) (off-label use): Administer just prior to meals (Abutair 2016; Feinglos 2013).
Irritable bowel syndrome (off-label use): Administer with meals by mixing with food, preferably yogurt (Bijkerk 2009).
Oral: Granules and powder must be mixed in 240 mL (8 ounce) of water or juice; drink 240 mL (8 ounce) of liquid with each dose of wafers or capsules; capsules should be swallowed one at a time. When more than one dose is required, divide throughout the day. Separate dose by at least 2 hours from other drug therapies. Avoid inhalation of psyllium dust; inhalation may cause sensitivity to psyllium (eg, runny nose, watery eyes, wheezing).
Constipation: Treatment of occasional constipation
Reduce risk of coronary heart disease: To reduce risk of coronary heart disease (CHD)
Dietary fiber supplement: Use as a dietary fiber supplement
Diabetes mellitus, type 2 (adjunctive therapy); Irritable bowel syndrome, unspecified
Fiberall may be confused with Feverall
None known.
There are no known significant interactions.
Psyllium is not absorbed systemically. When administered with adequate fluids, use is considered safe for the treatment of occasional constipation during pregnancy (Wald, 2003).
Products should be taken with at least 8 ounces of fluids. Some products may contain phenylalanine, potassium, sodium, as well as additional ingredients. Check individual product information for caloric and nutritional value.
When used to reduce the risk of CHD, the amount of soluble fiber from psyllium should be ≥7 g/day and it should be used in conjunction with a diet low in saturated fat and cholesterol.
Adequate intake for total fiber: Note: The definition of “fiber” varies; however, the soluble fiber in psyllium is only one type of fiber which makes up the daily recommended intake of total fiber.
2 to 3 years of age: 14 g/day (USDA/HHS 2020).
4 to 8 years of age: Female: 17 g/day; Male: 20 g/day (USDA/HHS 2020).
9 to 13 years of age: Female: 22 g/day; Male: 25 g/day (USDA/HHS 2020).
14 to 18 years of age: Female: 25 g/day; Male: 31 g/day (USDA/HHS 2020).
19 to 30 years of age: Female: 28 g/day; Male: 34 g/day (USDA/HHS 2020).
31 to 50 years of age: Female: 25 g/day; Male: 31 g/day (USDA/HHS 2020).
≥51 years of age: Female: 22 g/day; Male: 28 g/day (USDA/HHS 2020).
Pregnancy: USDA/HHS 2020:
14 to 18 years of age:
First trimester: 25 g/day.
Second trimester: 31 g/day.
Third trimester: 34 g/day.
19 to 30 years of age:
First trimester: 28 g/day.
Second trimester: 34 g/day.
Third trimester: 36 g/day.
31 to 50 years of age:
First trimester: 25 g/day.
Second trimester: 31 g/day.
Third trimester: 34 g/day.
Lactation: USDA/HHS 2020:
14 to 18 years of age: 31 g/day.
19 to 30 years of age: 34 g/day.
31 to 50 years of age: 31 g/day.
Psyllium is a soluble fiber. It absorbs water in the intestine to form a viscous liquid which promotes peristalsis and reduces transit time.
Onset of action: Relief of constipation: 12-72 hours
Absorption: None; small amounts of grain extracts present in the preparation have been reportedly absorbed following colonic hydrolysis
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟